Skip to content

Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary

Effectiveness of the Jeanne et Léon Program® on the Residents's Frailty in Temporary

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05659706
Acronym
FRAQOL
Enrollment
60
Registered
2022-12-21
Start date
2022-10-20
Completion date
2024-04-20
Last updated
2022-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residents's Frailty in Temporary Accommodation, Residents's Quality of Life in Temporary Accommodation

Keywords

Frailty, Quality of life, Health event

Brief summary

The management of frailty is a difficulty in the Temporary Accommodation Residences. Frailty represents a risk of reducing the activities of the elderly person. Jeanne & Léon Développement® offers an activity program that integrates several dimensions (physical and/or nutritional and/or social and/or psychological). To obtain the expected benefit, effect of the Jeanne & Léon® activities program on the residents's frailty and quality of life in temporary accommodation, the activity of at least one of these approaches is used as a global stimulant and thus activates the remaining skills to help fight against the frailty syndrome. In order to do this, the framework of the temporary accommodation, the group dynamics and the presence of a professional facilitator ensure the conditions for adherence to the program and promote the realization of stimulating activities. The phenomenon of activation initiated during the residential activity program can lead to an improvement in the components of frailty which is maintained over time. This will be assessed in terms of the occurrence of events after the activity program has been followed.

Detailed description

The clinical assessment will be performed by the investigating physician. Initial follow-up: Fragility and Quality of Life assessment is carried out by the trained nursing staff (doctor, nurse) of the Résidence Les Tamaris. The clinical assessment will include screening for thymic disorders. All experimenters will be specifically trained in the protocol and GCP beforehand. V0 (inclusion visit carried out within 72 hours after admission to the residence): inclusion after information and non-opposition, then randomization into the control group or the intervention group V1 (initial assessment visit performed within 96 hours after admission to the residence): initial assessment of the resident V2 (V1+ 21 days +/- 1 day: end of main study visit): final evaluation of the main study. In case of discharge from the Residence: validation of the contact information and the follow-up telephone schedule of the participant. Post-program follow-up: identification of intercurrent events by the Residence staff VS1 (V2 + 1 Month), SV2 (V2 + 3 Months): interview of participants by on-site follow-up or telephone call VS3 (V2 + 6 Months): on-site follow-up or final phone call.

Interventions

Mini Mental State Examination Charlson Comorbidity Index Katz Index ICOPE step 1 The 15-item geriatric depression scale (GDS-15) Medical Outcomes Study Short Form 36 (SF-36) Short Physical Performance Battery ( SPPB)

Sponsors

Gerontopôle des Pays de la Loire
CollaboratorOTHER
Jeanne et Leon Developpement
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Aged 60 years and over * Participant who has been living in temporary accommodation at the Résidence Les Tamaris for a maximum of 72 hours * Visual, auditory and oral or written abilities in French sufficient to complete the assessments and participate in the Jeanne & Léon® Program activities * Agrees to participate in the study and follow-ups for up to six months after the end of the activity program/temporary residence * Non-opposition accompanied by the information note co-signed by the investigator and the resident participating in the study, or the family member or the designated trusted person (if applicable) * Must be affiliated to a social security plan

Exclusion criteria

* Refusal to participate by the resident, family member or designated support person * Communication difficulties, sensory and/or motor deficits * Medical contraindication * Participant already included in another research protocol * Person under legal protection

Design outcomes

Primary

MeasureTime frameDescription
The endpoint will be a composite score, the FRAQOL, based on a combination of functional performance assessment (Short Physical Performance Battery (SPPB) composite test) and Quality of Life (Short Form 36 (SF-36) self questionnaire).8 monthsThe endpoint will be a composite score, the FRAQOL, based on a combination of functional performance assessment (Short Physical Performance Battery (SPPB) composite test) and Quality of Life (Short Form 36 (SF-36) self questionnaire). The Short Physical Performance Battery (SPPB) composite test and Short Form 36 (SF-36) self questionnaire will be assessed within 96 hours of admission to the residence, prior to program implementation, and then 3 weeks after the initial assessment SPPB: minimum value = 0 ; maximum value = 12 SPPB 0-6= Low performance SPPB 7-9 =Intermediate intermédiaires SPPB 10-12 =High performance SF36: minimum value = 0 ; maximum value = 100

Secondary

MeasureTime frameDescription
Evolution of each item of the scores Short Physical Performance Battery (SPPB) composite test15 monthsEvolution of each item of the scores Short Physical Performance Battery (SPPB) composite test
Evolution of each item of the Step 1 of ICOPE(Integrated Care for Older People)15 monthsEvolution of each item of the Step 1 of ICOPE(Integrated Care for Older People) no scores: answers yes/no to different items
Evolution of each item of the scores Short Form 36 self questionnaire15 monthsEvolution of each item of the scores Short Form 36 self questionnaire
Estimation of the incremental cost associated with the occurrence of intercurrent events up to six months after program completion15 monthsEstimation of the incremental cost associated with the occurrence of intercurrent events up to six months after program completion
Use of the ICOPE screening questionnaire responses as a descriptive element of the study population and analysis of a potential predictive relationship on the 6-month outcome.15 monthsUse of the ICOPE screening questionnaire responses as a descriptive element of the study population and analysis of a potential predictive relationship on the 6-month outcome.
Evolution of intercurrent health events of the composite score FRAQOL at one, three and six months after the end of the program15 monthsEvolution of intercurrent health events of the composite score FRAQOL at one, three and six months after the end of the program The objective is to estimate the frequency of occurrence of intercurrent health events of the composite score FRAQOL

Countries

France

Contacts

Primary ContactManon PONDJIKLI
manon.pondjikli@gerontopole-paysdelaloire.fr+33975121125
Backup ContactValentine DUTHEILLET DE LAMOTHE
valentine.dutheillet-de-lamothe@gerontopole-paysdelaloire.fr+33631114945

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026